NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
Jan Wehkamp(Robert Bosch Hospital), Eduard F. Stange(John Radcliffe Hospital), Elke Schäffeler(Robert Bosch Hospital), Miriam Schlee(Robert Bosch Hospital), Klaus Fellermann(Apple (Israel)), Florian Noack(Helmholtz Zentrum München), Matthias Schwab(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), K Herrlinger(Robert Bosch Hospital), Jürgen Harder(Christian-Albrechts-Universität zu Kiel), Andreas Stallmach(Jena University Hospital), Péter Fritz(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Charles Bevins(University of California, Davis), J.‐M. Schröder(Christian-Albrechts-Universität zu Kiel), Michael Weichenthal(Christian-Albrechts-Universität zu Kiel)
Cited by 798
Related Papers
A roadmap for graphene
|Nature|2012|9.1k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k
Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic
|Journal of Biological Chemistry|2001|1.3k
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969